Sequoia Financial Advisors LLC Has $943,000 Stock Position in Dolby Laboratories $DLB

Sequoia Financial Advisors LLC lifted its stake in Dolby Laboratories (NYSE:DLBFree Report) by 229.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,688 shares of the electronics maker’s stock after acquiring an additional 10,231 shares during the period. Sequoia Financial Advisors LLC’s holdings in Dolby Laboratories were worth $943,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Boothbay Fund Management LLC boosted its stake in Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after buying an additional 157 shares in the last quarter. Fifth Third Bancorp boosted its stake in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after buying an additional 192 shares in the last quarter. Gabelli Funds LLC boosted its stake in Dolby Laboratories by 0.4% during the third quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock worth $3,556,000 after buying an additional 202 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after buying an additional 220 shares in the last quarter. Finally, Raymond James Financial Inc. boosted its stake in Dolby Laboratories by 1.0% during the second quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after buying an additional 235 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Stock Down 2.0%

Dolby Laboratories stock opened at $54.28 on Thursday. The stock has a 50-day simple moving average of $61.52 and a 200 day simple moving average of $63.94. Dolby Laboratories has a 12-month low of $53.45 and a 12-month high of $77.64. The stock has a market capitalization of $5.14 billion, a price-to-earnings ratio of 21.46 and a beta of 0.86.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million during the quarter, compared to analysts’ expectations of $385.80 million. During the same period in the previous year, the business posted $1.34 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, sell-side analysts anticipate that Dolby Laboratories will post 3.22 EPS for the current year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories’s payout ratio is currently 56.92%.

Analysts Set New Price Targets

A number of research analysts have issued reports on DLB shares. Barrington Research reissued an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, January 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $90.75.

Get Our Latest Stock Report on DLB

Insider Activity at Dolby Laboratories

In related news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total value of $198,420.00. Following the completion of the sale, the senior vice president directly owned 83,218 shares in the company, valued at $5,504,038.52. This trade represents a 3.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ryan Nicholson sold 2,667 shares of Dolby Laboratories stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $66.38, for a total value of $177,035.46. Following the completion of the sale, the chief accounting officer owned 36,956 shares of the company’s stock, valued at approximately $2,453,139.28. The trade was a 6.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 18,021 shares of company stock valued at $1,090,741 over the last ninety days. 37.93% of the stock is owned by insiders.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.